Background: Androgen deprivation therapy (ADT) is extensively employed in treatment of
prostate cancer. Some studies have found increased risk of Alzheimer's disease and …

Background: Androgen deprivation therapy (ADT) is extensively used in prostate cancer. Yet
the risk of impaired cognition or Alzheimer disease (AD) in men with prostate cancer …

Abstract Background Prostate cancer (PCa) is one of the leading causes of death in Western
countries. Environmental and genetic factors play a pivotal role in PCa etiology. Timely …

Background Androgen deprivation therapy (ADT) is a standard treatment modality for locally
advanced, high‐risk, and metastatic hormone‐sensitive prostate cancer. Long‐term ADT …

Simple Summary Epidemiological studies have identified a link between neurodegenerative
disorders and a reduced risk of overall cancer. Increases and decreases in the risk of site …

Background. Prostate cancer (PCa) is one of the highest frequent malignant tumors with very
complicated pathogenesis. Genes of neurodegenerative diseases can influence tumor …

Alzheimer's disease (AD) and prostate cancer (PCa) are considered the leading causes of
death in elderly people worldwide. Although both these diseases have striking differences in …

Aim: The TP53 mutant is one of the most common mutant genes in prostate cancer.
Materials & methods: The RNA-seq data of prostate cancer was downloaded from TCGA …

Many studies have demonstrated the mechanisms of progression to castration-resistant
prostate cancer (CRPC) and novel strategies for its treatment. Despite these advances, the …

Background: Prostate cancer (PCa) is an epithelial malignant tumor that occurs in the
urinary system with high incidence and is the second most common cancer among men in …